The NIRVANA field-test kit
Credit: Mo Li/KAUST
The field test, called NIRVANA, can simultaneously detect and sequence SARS-CoV-2, influenza and other viruses
Clinicians using a new viral screening test can not only diagnose COVID-19 in a matter of minutes with a portable, pocket-sized machine, but can also simultaneously test for other viruses—like influenza—that might be mistaken for the coronavirus. At the same time, they can sequence the virus, providing valuable information on the spread of COVID-19 mutations and variants. The new test, dubbed NIRVANA, was described online today by a multi-institution team of scientists in the journal Med.
“This is a virus detection and surveillance method that doesn’t require an expensive infrastructure like other approaches,” says Juan Carlos Izpisua Belmonte, co-corresponding author and a professor in Salk’s Gene Expression Laboratory. “We can accomplish with one portable test the same thing that others are using two or three different tests, with different machines, to do.”
Around the world, more than 100 million people have been infected with SARS-CoV-2, the virus that causes COVID-19. A staggering 500,000 Americans have died from COVID-19 to date. Testing the population is key to stopping the spread of the virus. In addition, tracking the spread of new SARS-CoV-2 variants—some of which could respond differently to treatments or vaccines—is critical.
Today, the standard approach to determining whether a nasal swab is positive for COVID-19 is to run a polymerase chain reaction (PCR) test to detect genetic material from the SARS-CoV-2 virus. If the sample is negative, however, patients and clinicians don’t get any information on what might be causing the coronavirus-like symptoms—unless they run separate PCR tests, using different swab samples, for other viruses. And if the sample is positive for SARS-CoV-2, they don’t learn which COVID-19 variant a patient is infected with unless another set of tests is run; those require a large and expensive next-generation gene-sequencing machine.
Last summer, Mo Li, an assistant professor of bioscience at King Abdullah University of Science and Technology in Saudi Arabia, was pondering ways he could lend his expertise in genetic engineering and nanopore sequencing to combatting the COVID-19 pandemic. Li, who previously spent six years as a Salk postdoctoral researcher in the Izpisua Belmonte lab, wondered whether a gene-detection approach called isothermal recombinase polymerase amplification (RPA) coupled with real-time nanopore sequencing might be more useful—and faster, cheaper and more portable—than the current COVID-19 testing approach. He teamed up with Izpisua Belmonte to find out.
Unlike PCR, which cycles through lower and higher temperatures to separate DNA strands and copy them, RPA uses proteins—rather than temperature changes—to accomplish the same thing in only 20 minutes. The technology lets researchers copy longer stretches of DNA, and probe for multiple genes at the same time.
“We quickly realized that we could use this technique to not only detect SARS-CoV-2, but other viruses at the same time,” says Li.
In the new paper, Li and Izpisua Belmonte describe a small, portable device that can screen 96 samples at the same time using the RPA assay. They call the method NIRVANA, for “nanopore sequencing of isothermal rapid viral amplification for near real-time analysis.”
The scientists designed NIRVANA to simultaneously test samples for COVID-19, influenza A, human adenovirus, and non-SARS-CoV-2 human coronavirus. In just 15 minutes, the researchers report, the device begins to report positive and negative results. And within three hours, the device finalizes results on all 96 samples—including the sequences of five regions of SARS-CoV-2 that are particularly prone to accumulate mutations leading to new variants such as the B.1.1.7 variant identified in the UK.
Li and Izpisua Belmonte tested NIRVANA on 10 samples known to be positive for SARS-CoV-2, 60 samples of unknown SARS-CoV-2 status, as well as samples of municipal wastewater harboring the SARS-COV-2 virus and others. In all cases, the assay was able to correctly identify which viruses were present. The sequencing data also allowed them to narrow down the origin of SARS-CoV-2 in positive samples; differentiating strains from China and Europe, for instance.
“The design of this assay is really flexible, so it’s not just limited to the examples we’ve shown,” says Li. “We can easily adapt it to tackle another pathogen, even something new and emergent.”
With the small size and portability of the NIRVANA workflow, it could be used for fast virus detection at schools, airports or ports, the researchers say. It also could be used to monitor wastewater or streams for the presence of new viruses.
“The pandemic has provided two important lessons: first, test widely and quickly, and second, know your variants. Our NIRVANA method provides a promising solution to these two challenges not only for the current pandemic but also for possible future ones,” says Izpisua Belmonte, who holds the Roger Guillemin Chair at Salk. Market analysis would be required to determine whether the initial cost of commercialization—and the constant tweaks to the test needed to make sure it detected new variants or new viruses of interest—are worth it, Belmonte adds.
Original Article: Fast, portable test can diagnose COVID-19 and track variants
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Virus field test
- USC COVID-19 testing worker fired after reporting test site virus exposureon July 2, 2021 at 9:15 am
A COVID-19 testing worker at the University of South Carolina sounded the alarm about an exposure to the deadly virus for employees and hundreds coming in for testing. Days later ...
- Columbia company gets American-made, virus-killing products to schools, hospitalson July 2, 2021 at 6:55 am
After gaining national attention as an N95 mask distributor, this Columbia startup has continued to get out new products that they say will make schools and hospitals safer.
- No lockdown plans in Russia as virus deaths hit new recordon July 2, 2021 at 4:36 am
Russian authorities reported a record-breaking 679 new coronavirus deaths on Friday, a fourth day in a row with the highest daily death toll in the pandemic. No plans for a lockdown ...
- Virus Research or Naturally Occurring Pathogenon July 2, 2021 at 4:00 am
Governments need to upgrade the transparency, oversight, and biosafety of any projects seeking dangerous pathogens for laboratory study.
- From Alpha to Delta, Why Virus Mutations Cause Alarmon July 2, 2021 at 1:28 am
Viruses mutate all the time, including the SARS-CoV-2 coronavirus that’s caused the Covid-19 pandemic. Although most genetic changes are innocuous, some can make the mutant more adept at infecting ...
Go deeper with Google Headlines on:
Virus field test
Go deeper with Bing News on:
Viral screening test
- Rapid COVID-19 tests should be rolled out in high risk settings, but not in the general community, experts sayon July 1, 2021 at 7:13 pm
With the country grappling multiple outbreaks, and some people facing long queues to get tested, should we be rolling out rapid COVID tests across the community?
- Frequent testing improves the detection of SARS-CoV-2on June 30, 2021 at 9:57 pm
Employees and students at UIUC participate in SHIELD Illinois, a COVID-19 screening program implemented ... The sensitivity of PCR molecular tests and rapid antigen tests is highest when viral ...
- Effectively monitoring COVID-19 in reopened educational institutions: the San Diego modelon June 30, 2021 at 8:39 am
An interesting new study from the University of California San Diego (UCSD) shows that using preventive measures to block viral transmission, coupled with repeated testing and rapid turnaround times ...
- NIH-funded screening study builds case for frequent COVID-19 antigen testingon June 30, 2021 at 6:36 am
CoV-2, the virus that causes COVID-19, improves with regularity of testing, whether using rapid antigen tests or PCR molecular tests. The PCR test is considered the gold standard for diagnosing ...
- Getting a PCR test for return to Scotland from Iceland?on June 25, 2021 at 11:10 am
If I've read the Scottish guidance right, then I need a PCR test before I return to Scotland from Iceland. Where is the best place to get one of these sorted out? The Covid.is website has a section ...